Current status of HIV therapy: II. Opportunistic diseases.

Feinberg, J; Hoth, D F

Feinberg, J; Hoth, D F.

Affiliation

Feinberg J; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore.

Hosp Pract (Off Ed) ; 26(3): 105-13, 1991 Mar 15.

Article in En | MEDLINE | ID: mdl-1900845

Subject(s)

Acquired Immunodeficiency Syndrome/complications; Anti-Bacterial Agents/administration & dosage; Histoplasmosis/complications; Opportunistic Infections/complications; Pentamidine/therapeutic use; Pneumonia, Pneumocystis/complications; Sarcoma, Kaposi/complications; Acquired Immunodeficiency Syndrome/mortality; Antineoplastic Agents/therapeutic use; Ganciclovir/therapeutic use; Histoplasmosis/drug therapy; Humans; Male; Multicenter Studies as Topic; Opportunistic Infections/drug therapy; Opportunistic Infections/prevention & control; Pneumonia, Pneumocystis/prevention & control; Sarcoma, Kaposi/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pentamidine / Pneumonia, Pneumocystis / Sarcoma, Kaposi / Opportunistic Infections / Acquired Immunodeficiency Syndrome / Histoplasmosis / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Hosp Pract (Off Ed) Year: 1991 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links